Market Cap 179.34M
Revenue (ttm) 0.00
Net Income (ttm) -41.52M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 1,885,900
Avg Vol 1,045,566
Day's Range N/A - N/A
Shares Out 84.99M
Stochastic %K 53%
Beta 0.61
Analysts Sell
Price Target $3.50

Company Profile

Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines in the United States and Canada. The company's lead product candidate is etripamil, a novel and potent calcium channel blocker, which has completed phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia; and Phase II clinical trial for the treatment of atrial fibrillation and rapid ventricular rate. It has a license and collabora...

Industry: Biotechnology
Sector: Healthcare
Phone: 514-336-0444
Address:
1111 Dr. Frederik-Philips Boulevard, Suite 420, Montreal, Canada
Syndr78
Syndr78 Oct. 4 at 1:06 AM
$MIST If management were smart, and i think most here agree that they're not, they should already be in negotiations with BP to sell the company into more financially capable, and phase 3 trial and NDA submitting hands.
0 · Reply
Syndr78
Syndr78 Oct. 4 at 12:54 AM
$MIST I'm bullish for the run up. But, with no mention of AFIB PH3, nor pursuit of European approval, I'm very skeptical about a very significant sell off, as seen with TNXP. I feel like approval may FINALLY, and arguably should be expected... And therefore baked in. We haven't heard much from management in a long time, regarding commercialization preparedness. And, even with dilution and the 75 million influx, a LOT of time and money has been lost since the CRL in March. Market penetration and revenue are a long way off. And they've already said back in March during the presentation that they will be delaying phase 3 and EU approval until psvt gets up and running. I wouldn't be overly optimistic about a huge stock price during the run-up, or even after approval. I'm hopeful that someone here can make counter points, and am looking forward to hearing them.
3 · Reply
Postergirl
Postergirl Oct. 4 at 12:10 AM
$MIST https://www.fiercebiotech.com/regulatory/updated-what-happens-to-fda-a-government-shutdown.
0 · Reply
TheGreedyGrench
TheGreedyGrench Oct. 3 at 7:08 PM
$MIST Ouch! gap fill back in the .80s
2 · Reply
equitiesrus
equitiesrus Oct. 3 at 6:40 PM
$MIST rinse and repeat between 1.8 and 2.1 for another month.
0 · Reply
14kmaker
14kmaker Oct. 3 at 6:39 PM
$MIST gap has filled- going upwards now
0 · Reply
Morslan
Morslan Oct. 3 at 6:16 PM
$MIST friday selloff It was so goood !!
0 · Reply
PoloReb
PoloReb Oct. 3 at 5:26 PM
$MIST buying the dips! It’s only going to continue going up the next two months
0 · Reply
Shawhwk
Shawhwk Oct. 3 at 3:23 PM
1 · Reply
ShorterNew
ShorterNew Oct. 3 at 2:30 PM
$MIST how come there are so many seller posts as soon as it started climbing. Coincidence or intentional?
0 · Reply
Latest News on MIST
Milestone® Pharmaceuticals to Present at Upcoming Conferences

Aug 19, 2025, 8:00 AM EDT - 6 weeks ago

Milestone® Pharmaceuticals to Present at Upcoming Conferences


Crude Oil Rises Sharply; Milestone Pharmaceuticals Shares Plunge

Jul 11, 2025, 2:37 PM EDT - 3 months ago

Crude Oil Rises Sharply; Milestone Pharmaceuticals Shares Plunge


Milestone Pharmaceuticals Announces Proposed Public Offering

Jul 11, 2025, 6:01 AM EDT - 3 months ago

Milestone Pharmaceuticals Announces Proposed Public Offering


FDA Issues Complete Response Letter for Etripamil for PSVT

Mar 28, 2025, 7:00 AM EDT - 6 months ago

FDA Issues Complete Response Letter for Etripamil for PSVT


Syndr78
Syndr78 Oct. 4 at 1:06 AM
$MIST If management were smart, and i think most here agree that they're not, they should already be in negotiations with BP to sell the company into more financially capable, and phase 3 trial and NDA submitting hands.
0 · Reply
Syndr78
Syndr78 Oct. 4 at 12:54 AM
$MIST I'm bullish for the run up. But, with no mention of AFIB PH3, nor pursuit of European approval, I'm very skeptical about a very significant sell off, as seen with TNXP. I feel like approval may FINALLY, and arguably should be expected... And therefore baked in. We haven't heard much from management in a long time, regarding commercialization preparedness. And, even with dilution and the 75 million influx, a LOT of time and money has been lost since the CRL in March. Market penetration and revenue are a long way off. And they've already said back in March during the presentation that they will be delaying phase 3 and EU approval until psvt gets up and running. I wouldn't be overly optimistic about a huge stock price during the run-up, or even after approval. I'm hopeful that someone here can make counter points, and am looking forward to hearing them.
3 · Reply
Postergirl
Postergirl Oct. 4 at 12:10 AM
$MIST https://www.fiercebiotech.com/regulatory/updated-what-happens-to-fda-a-government-shutdown.
0 · Reply
TheGreedyGrench
TheGreedyGrench Oct. 3 at 7:08 PM
$MIST Ouch! gap fill back in the .80s
2 · Reply
equitiesrus
equitiesrus Oct. 3 at 6:40 PM
$MIST rinse and repeat between 1.8 and 2.1 for another month.
0 · Reply
14kmaker
14kmaker Oct. 3 at 6:39 PM
$MIST gap has filled- going upwards now
0 · Reply
Morslan
Morslan Oct. 3 at 6:16 PM
$MIST friday selloff It was so goood !!
0 · Reply
PoloReb
PoloReb Oct. 3 at 5:26 PM
$MIST buying the dips! It’s only going to continue going up the next two months
0 · Reply
Shawhwk
Shawhwk Oct. 3 at 3:23 PM
1 · Reply
ShorterNew
ShorterNew Oct. 3 at 2:30 PM
$MIST how come there are so many seller posts as soon as it started climbing. Coincidence or intentional?
0 · Reply
Lh2838
Lh2838 Oct. 3 at 2:26 PM
0 · Reply
GQTrit
GQTrit Oct. 3 at 2:18 PM
$MIST You guys crack me up. Anyway all proceeds went to $PEPG
1 · Reply
Rroper
Rroper Oct. 3 at 2:10 PM
$MIST Me loves this long time. Holding for the run up. Getting close.
1 · Reply
Consti22
Consti22 Oct. 3 at 1:55 PM
$MIST Sell? That would be totally stupid. It's just getting started. 💪
1 · Reply
FitzCatalyst
FitzCatalyst Oct. 3 at 1:32 PM
$MIST very nice
0 · Reply
GQTrit
GQTrit Oct. 3 at 12:37 PM
$MIST For those of you that were brave enough to follow me at $1.50 in the the face of short sellers spewing garbage, I humbly say thank you. I think it is prudent we take some 50% profits today. MY plan YOUR money.
2 · Reply
Consti22
Consti22 Oct. 3 at 11:06 AM
1 · Reply
PsychTrades
PsychTrades Oct. 3 at 4:49 AM
$MIST up nearly 7% on 2.2 mil volume. Looking good, though mind the inevitable manipulation games 🍻
1 · Reply
CCC501
CCC501 Oct. 3 at 2:15 AM
$MIST Approval imminent?
0 · Reply
Bellz22
Bellz22 Oct. 2 at 9:22 PM
$MIST beautiful day today
0 · Reply
QuantInsider
QuantInsider Oct. 2 at 8:53 PM
What’s happening with $MIST? We’re seeing a nice pop, up 6.34% today and 11.22% over the last 5 days Momentum is there but no fresh news to back it up Two ask-side sweeps on Dec $2.5 calls, 908 contracts at $0.45 That’s about $40.9k, hinting at some tactical upside With high IV around 140%, these are pricey Without a catalyst, it’s all about momentum here Keep risk defined Consider call spreads over naked calls to manage that IV crush Stay sharp
0 · Reply
PoloReb
PoloReb Oct. 2 at 8:47 PM
$MIST nice movement today!
0 · Reply